Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.53 |
| ▸ | HTR6 | P50406 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25645586 | 0.98 | ADRA2A (0.51) | ADRA2AHTR6 | |
| SCHEMBL11470450 | 0.98 | ADRA2A (0.51) | ADRA2AHTR6 | |
| Ammonia Solution, Strong SCHEMBL3645001 | 0.98 | ADRA2A (0.51) | ADRA2AHTR6 | |
| SCHEMBL3764570 | 0.95 | HTR6 (0.54) | HTR6 | |
| SCHEMBL16488227 | 0.95 | HTR6 (0.54) | HTR6 | |
| Hydrochloric Acid SCHEMBL28216900 | 0.93 | HTR6 (0.55) | HTR6 | |
| SCHEMBL4278447 | 0.83 | CHRNB2 (0.49) | ADRA2AHTR6 | |
| SCHEMBL9963995 | 0.83 | SLC18A2 (0.68) | ADRA2A | |
| SCHEMBL8106512 | 0.83 | ADRA2A (0.47) | ADRA2AHTR6 | |
| Ammonia Solution, Strong SCHEMBL29771408 | 0.81 | HTR1D (0.49) | HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12429483-B2 | System and method for determining onset and disease progression | RESPIRATION SCAN LTD (IL) | 2025-09-30 | — | — | US | claimed |
| US-12429483-B2 | System and method for determining onset and disease progression | RESPIRATION SCAN LTD (IL) | 2025-09-30 | — | — | US | disclosed |
| EP-4164481-B1 | A DEVICE FOR MEASURING VOLATILE MARKERS IN BREATH | NANOSE MEDICAL LTD (IL) | 2024-10-16 | — | — | EP | disclosed |
| CN-117700657-A | Poly (4-aryl) piperidine polymer, preparation method and prepared anion exchange membrane | 西湖大学 | 2024-03-15 | — | — | CN | disclosed |
| US-20230337934-A1 | A DEVICE FOR MEASURING VOLATILE MARKERS IN BREATH | NANOSE MEDICAL LTD (IL) | 2023-10-26 | — | — | US | disclosed |
| WO-2023107557-A1 | COMPOUNDS AND COMPOSITIONS THAT INHIBIT PIKFYVE | Kineta, Inc. (US) | 2023-06-15 | — | — | WO | disclosed |
| US-20230183224-A1 | BEZOXAZINE DERIVATIVES USEFUL AS MONOACYLGLYCEROL LIPASE INHIBITORS | HOFFMANN-LA ROCHE INC. (US) | 2023-06-15 | — | — | US | disclosed |
| EP-4164481-A1 | A DEVICE FOR MEASURING VOLATILE MARKERS IN BREATH | Nanose Medical Ltd (IL) | 2023-04-19 | — | — | EP | disclosed |
| US-20220317122-A1 | SYSTEM AND METHOD FOR DETERMINING ONSET AND DISEASE PROGRESSION | RESPIRATION SCAN LTD. (IL) | 2022-10-06 | — | — | US | disclosed |
| EP-4013302-A1 | SYSTEM AND METHOD FOR DETERMINING ONSET AND DISEASE PROGRESSION | Respiration Scan Ltd (IL) | 2022-06-22 | — | — | EP | disclosed |
| US-20110015178-A1 | Amido-Thiophene Compounds and Their Use | THE UNIVERSITY OF EDINBURGH (GB) | 2011-01-20 | — | — | US | disclosed |
| WO-2010146338-A1 | AMIDO-ISOTHIAZOLE COMPOUNDS AND THEIR USE AS INHIBITORS OF 11BETA-HSD1 FOR THE TREATMENT OF METABOLIC SYNDROME AND RELATED DISORDERS | THE UNIVERSITY OF EDINBURGH (GB) | 2010-12-23 | — | — | WO | disclosed |
| WO-2009112845-A1 | AMIDO-THIOPHENE COMPOUNDS AND THEIR USE | THE UNIVERSITY OF EDINBURGH (GB) | 2009-09-17 | — | — | WO | disclosed |
| US-7459460-B2 | Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-12-02 | — | — | US | disclosed |
| WO-2008062235-A1 | THERAPEUTIC G-QUADRUPLEX LIGANDS | SCHOOL OF PHARMACY, UNIVERSITY OF LONDON (GB) | 2008-05-29 | — | — | WO | disclosed |
| US-7300930-B2 | Therapeutic acridone and acridine compounds | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2007-11-27 | — | — | US | disclosed |
| US-7300930-B2 | Therapeutic acridone and acridine compounds | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2007-11-27 | — | — | US | disclosed |
| US-7205311-B2 | Therapeutic acridone and acridine compounds | CANCER RESEARCH TECHNOLOGY LIMITED | 2007-04-17 | — | — | US | disclosed |
| US-7205311-B2 | Therapeutic acridone and acridine compounds | CANCER RESEARCH TECHNOLOGY LIMITED | 2007-04-17 | — | — | US | disclosed |
| US-7160896-B2 | Therapeutic acridone and acridine compounds | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2007-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183224-A1 | BEZOXAZINE DERIVATIVES USEFUL AS MONOACYLGLYCEROL LIPASE INHIBITORS | LPL, LIPC, PNLIP | ADRA2A 1046/4885HTR6 4422/4885 |
| US-20110015178-A1 | Amido-Thiophene Compounds and Their Use | HSD11B1, HSD11B2, HSD17B1 | ADRA2A 1565/4885HTR6 918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.